Home › Trial NCT06671548
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- Trial IDNCT06671548
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorQilu Pharmaceutical Co., Ltd.
- Enrollment120
- Start date2024-01-15
- ConditionsHeavy Menstrual Bleeding · Uterine Fibroids
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.